Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ABBV Relative to the S&P 500

ABBV Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the AbbVie Inc. (NYSE:ABBV) seasonal charts above shows that a Buy Date of October 28 and a Sell Date of January 19 has resulted in a geometric average return of 6.54% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is an excellent rate of success and the return outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 1.07% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

To download ABBV seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ABBV